IM19 CAR-T Cell Therapy

· Beijing Immunochina Medical Science & Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for IM19 CAR-T Cell Therapy, covering 2024-11-26 to 2025-08-17. Get the full timeline:

Most recent: Clinical Trial Update: IM19 CAR-T Cell Therapy in Refractory Systemic Lupus Erythematosus (SLE) [NA]